Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE393 Vaccination-Challenge Study for Campylobacter
NCT00859716Phase 2Unknown
- Start
- Oct 2008
- Primary completion
- Mar 2009
- Modality
- Prophylactic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ACE393 in campylobacteriosis. Status: unknown.
02
Drugs
ACE393
03
Conditions
campylobacteriosis
Beyond the preview
Go deeper on NCT00859716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859716.